Cycc stock forecast discussions among market forums lean
CYCC stock forecast discussions among market forums lean toward a “buy on dips” approach given current sector multiples. Valuation screens suggest upside potential if peer small-cap biotechs sustain momentum. Cyclacel Pharmaceuticals Stock Forecast: up to 4.918 USD ... Net loss for the three months ended June 30, 2025, was $1.3 million (including stock-based compensation expense of $7,000) , compared to $3.3 million (including stock-based compensation expense of $0.2 million ) for the same period in 2024. Technical CYCC stock forecast notes show the stock is testing upper Bollinger Band limits, a setup that often precedes volatility spikes. Watch $2.18 as a tactical breakout zone.
Return this item for free
We offer easy, convenient returns with at least one free return option: no shipping charges. All returns must comply with our returns policy.
Learn more about free returns.- Go to your orders and start the return
- Select your preferred free shipping option
- Drop off and leave!